William R. Larue is CFO & SVP +2 at CADENCE PHARMACEUTICALS INC (CADX). They have made 2 open-market trades across 1 company since 2011, most recently 2022-12-21.
CIK 0001265784
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCON | SELL | 2022-12-21 | 2023-01-19 | $1.26 | $151 | -3.4% | -2.9% | +4.6% |
| TCON | BUY | 2021-07-26 | 2021-07-27 | $3.82 | $25K | -3.2% | +1.6% | -5.3% |
| TCON | SELL · 10b5-1 | 2017-06-02 | 2017-06-05 | $2.69 | $7K | -18.9% | -9.4% | +24.5% |
| CADX | SELL · 10b5-1 | 2013-12-17 | 2013-12-18 | $9.12 | $78K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-11-15 | 2013-11-18 | $7.30 | $263K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-07-17 | 2013-07-17 | $7.26 | $65K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-06-25 | 2013-06-27 | $7.20 | $65K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2011-11-21 | 2011-11-22 | $4.16 | $42K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.